Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.1%

1 terminated out of 32 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

19%

6 trials in Phase 3/4

Results Transparency

33%

5 of 15 completed with results

Key Signals

5 with results94% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (3)
P 1 (2)
P 2 (7)
P 3 (3)
P 4 (3)

Trial Status

Completed15
Unknown7
Recruiting5
Active Not Recruiting3
Terminated1
Suspended1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT05947071Phase 2Recruiting

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

NCT01295645Phase 2Active Not RecruitingPrimary

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

NCT04613206Phase 2Active Not Recruiting

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

NCT05215327Phase 2Recruiting

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

NCT05198570Recruiting

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients

NCT04579471Recruiting

Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study

NCT03699254Phase 3CompletedPrimary

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

NCT05047406Phase 2UnknownPrimary

Bacillus Clausii in Liver Transplantation

NCT02294032Completed

The Role of B Cells in Kidney Allograft Dysfunction

NCT05193058UnknownPrimary

Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome

NCT01515605RecruitingPrimary

Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation

NCT04281797UnknownPrimary

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

NCT01808456Phase 4Completed

Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.

NCT02329808Completed

Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

NCT01972035Phase 2CompletedPrimary

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

NCT04336735Not ApplicableUnknownPrimary

Improving Immunization Rates in Transplant Candidates Through the Use of a Health Information Technology Tool

NCT01471444Phase 3Completed

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

NCT00473824Phase 2Terminated

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

NCT04320303Not ApplicableUnknown

CMV Infection and Immune Intervention After Transplantation

NCT02463214Not ApplicableCompletedPrimary

Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients

Scroll to load more

Research Network

Activity Timeline